It is consistent with a previous report that positive EGFR mutation provided longer postoperative survival for NSCLC patients undergoing palliative surgical treatment for spinal metastases (HR = 2.10, p = 0.002) [35]. Here, EGFR is linked to non-small cell lung carcinoma.